BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 31811914)

  • 1. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.
    Patel A; Kaur H; Xess I; Michael JS; Savio J; Rudramurthy S; Singh R; Shastri P; Umabala P; Sardana R; Kindo A; Capoor MR; Mohan S; Muthu V; Agarwal R; Chakrabarti A
    Clin Microbiol Infect; 2020 Jul; 26(7):944.e9-944.e15. PubMed ID: 31811914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
    Bala K; Chander J; Handa U; Punia RS; Attri AK
    Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.
    Prakash H; Ghosh AK; Rudramurthy SM; Singh P; Xess I; Savio J; Pamidimukkala U; Jillwin J; Varma S; Das A; Panda NK; Singh S; Bal A; Chakrabarti A
    Med Mycol; 2019 Jun; 57(4):395-402. PubMed ID: 30085158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases.
    Corzo-León DE; Chora-Hernández LD; Rodríguez-Zulueta AP; Walsh TJ
    Med Mycol; 2018 Jan; 56(1):29-43. PubMed ID: 28431008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.
    Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E;
    BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases.
    Samaddar A; Shrimali T; Sharma A
    Mycoses; 2023 Mar; 66(3):181-195. PubMed ID: 36227645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases.
    Bonifaz A; Tirado-Sánchez A; Hernández-Medel ML; Araiza J; Kassack JJ; Del Angel-Arenas T; Moisés-Hernández JF; Paredes-Farrera F; Gómez-Apo E; Treviño-Rangel RJ; González GM
    Mycoses; 2021 Apr; 64(4):372-380. PubMed ID: 33253454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous mucormycosis.
    Skiada A; Petrikkos G
    Skinmed; 2013; 11(3):155-9; quiz 159-60. PubMed ID: 23930354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM).
    Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Panigrahi MK; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
    Mycoses; 2024 May; 67(5):e13745. PubMed ID: 38767273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mucormycosis: retrospective evaluation of 12 cases].
    Arda B; Erdem A; Sipahi OR; Işıkgöz Taşbakan M; Pullukçu H; Taşbakan MS; Ceylan N; Metin DY; Midilli R; Yamazhan T; Ulusoy S
    Mikrobiyol Bul; 2011 Jul; 45(3):504-11. PubMed ID: 21935783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucormycosis due to Apophysomyces species complex- 25 years' experience at a tertiary care hospital in southern India.
    Pamidimukkala U; Sudhaharan S; Kancharla A; Vemu L; Challa S; Karanam SD; Chavali P; Prakash H; Ghosh AK; Gupta S; Rudramurthy SM; Chakrabarti A
    Med Mycol; 2020 Jun; 58(4):425-433. PubMed ID: 31342074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
    Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
    Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.
    Chowdhary A; Kathuria S; Singh PK; Sharma B; Dolatabadi S; Hagen F; Meis JF
    Mycoses; 2014 Dec; 57 Suppl 3():97-107. PubMed ID: 25250768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucormycosis.
    Reid G; Lynch JP; Fishbein MC; Clark NM
    Semin Respir Crit Care Med; 2020 Feb; 41(1):99-114. PubMed ID: 32000287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucormycosis in India: unique features.
    Chakrabarti A; Singh R
    Mycoses; 2014 Dec; 57 Suppl 3():85-90. PubMed ID: 25187095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucormycosis-A clinicoepidemiological review of cases over 10 years.
    Manesh A; Rupali P; Sullivan MO; Mohanraj P; Rupa V; George B; Michael JS
    Mycoses; 2019 Apr; 62(4):391-398. PubMed ID: 30685896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucormycosis in Iran: a systematic review.
    Vaezi A; Moazeni M; Rahimi MT; de Hoog S; Badali H
    Mycoses; 2016 Jul; 59(7):402-15. PubMed ID: 26906121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-COVID-19 rhino-orbito-cerebral mucormycosis-A clinico-mycological study from North India.
    Taneja J; Chatterjee K; Sasidharan J; Abbas SZ; Rai AK; Raychaudhury S; Das B; Das A
    Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37442616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucormycosis: New Developments into a Persistently Devastating Infection.
    Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F
    Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.